EBOS GROUP LIMITED — Share Issue/Capital Change 2025

Apr 17, 2025

Capital Change Notice

==> picture [101 x 49] intentionally omitted <==

==> picture [90 x 31] intentionally omitted <==

Section 1: Issuer information
Name of issuer	EBOS Group Limited
NZX ticker code	EBO
Class of financial product	Ordinary Shares
ISIN (If unknown, check on NZX website)	NZEBOE0001S6
Currency	NZD / AUD
Section 2: Capital change details
Number issued/acquired/redeemed	5,926,876
Nominal value (if any)	Not applicable
Issue/acquisition/redemption price per security	NZ$36.65 or A$33.69 (which has been determined by reference to the NZ$:A$ exchange rate as reported by the Reserve Bank of Australia as at 4pm AEST on 10 April 2025)
Nature of the payment (for example, cash or other consideration)	Cash
Amount paid up (if not in full)	Not applicable
Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence)	3.02842811%
For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date)	Not applicable
Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here)	Issue of ordinary shares under a placement conducted by EBO. The placement was conducted in connection with EBO funding the acquisition of SVS Veterinary Supplies and the acquisition of the final 10% stake in Transmedic Pte Ltd. Funds raised in excess of the acquisition consideration will provide further balance sheet capacity to fund additional future growth opportunities.
Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption.	201,634,873 None held as Treasury Stock

In the case of an acquisition of shares, whether those shares are to be held as treasury stock	Not applicable
Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made	Board resolution dated 30 March 2025 and directors’ certificate dated 31 March 2025 for the issue pursuant to NZX listing Rules 4.3 and 4.5
Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements)	New ordinary shares which rank equally with all other fully paid ordinary shares in EBO
Date of issue/acquisition/redemption	17/04/2025
Section 3: Disclosure required for Placements made under Rule 4.5.1
Details of the approach in identifying investors who were able to participate in the offer and how their respective allocations in the offer were determined. The explanation must set out the key objectives and criteria the Issuer adopted in the allocation process, whether one of those objectives was a best effort to allocate on a pro rata basis to existing holders of the Issuer’s Equity Securities, and any significant exceptions or deviations from those objectives and criteria.	Having regard to the objectives which supported EBO’s choice of offer structure (being a Placement and Retail Offer), EBO’s objectives and criteria for allocations under the Placement were: • maximise participation by existing shareholders through broad eligibility and widely marketing the offer through various channels; • allocate existing shareholders at least their pro- rata equivalent on a ‘best efforts’ basis, subject to their demand; • strengthen EBOS’ share register; and • make allocations above pro-rata having regard to the following criteria: o quality of investor (including size and investment thesis); o support of EBO to date (including existing or previous shareholders, length of shareholding, size of investment); o the timing of the investor’s interest (in particular, how early in the offering process the investor expressed interest), seeking to prioritise investors that provide early bids and deal leadership; o the size of an investor’s expressed interest (both absolutely and relative to the investor’s portfolio) or assets under management; o location of the investor and any applicable selling restrictions or other relevant legal or regulatory restrictions in jurisdictions with which the investor is located. Final allocation decisions were made by EBO, and reflected input and advice from the Lead Manager of the offer. There were no significant exceptions or deviations from the objectives and criteria set out above.
Section 4: Authority for this announcement and contact person
Name of person authorised to make this announcement	Janelle Cain, General Counsel
Contact person for this announcement	Janelle Cain
Contact phone number	+61 (3) 9918 5555
Contact email address	Janelle.Cain@ebosgroup.com
Date of release through MAP	17/04/2025